MIRA (mirapharmaceuticals.com) יחס שווי שוק לשווי בספרים

MIRA Pharmaceuticals (MIRA) is a biotech developer creating advanced methods to combat neurological pathologies and pain syndromes based on patent-protected molecules. This daily price chart reflects the dynamics of an asset whose price at 2.93 currently prices in speculative demand ahead of the test results. In the long term, the synthesis of cannabinoids could grant the company monopolist status with the pricing power to independently determine market pricing.

This ratio compares the current market value of shares to the amount of equity. It measures the premium investors are willing to pay for the business's net assets. The formula's dynamics react sharply to quarterly balance sheet changes. By analyzing the ratio of market value to book capitalization, one can identify asset overvaluation. For MIRA Pharmaceuticals (MIRA), this reflects market confidence in the potential of safe non-opioid drugs.